A clinical-stage biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases
Amsterdam, The NetherlandsBiotech
2 sources · checked 1 time, last 23m ago
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $82.9M €74.5 million ($83.5 million) | 2026-11-11 | not stated | 1 person on X · 1 outlet. #60 in Trending |
2 sources · checked 1 time, last 23m ago [ VERIFIED · CORRECTED ] read against 2 sources [ BUILT WITH ]·[ SEARCH ]found on a watched publisher·[ SCRAPE ]2 pages read: businesswire.com, thepharmaletter.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage·[ ]posts from 1 person, found with Firecrawl search | ||||
Found on X with Firecrawl search